The effect of oral treatment with 6-O-butanoyl castanospermine (MDL 28,574) in the murine zosteriform model of HSV-1 infection

Glycobiology

Volumn 5, Issue 2, 1995, Pages 249-253

  Bridges, C Gordon ^a   Ahmed, S Parvin ^a   Kang, Mohinder S ^a,b   Nash, Robert J ^a,c   Porter, Elaine A ^a,d   Tyms, A Stanley ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b Merrell Dow Research Institute   (United States)

^c ABERYSTWYTH UNIVERSITY   (United Kingdom)

^d ROYAL BOTANIC GARDENS   (United Kingdom)

Author keywords

6 O butanoyl castanospermine; HSV 1; Zosteriform model

Indexed keywords

ACICLOVIR; ALPHA GLUCOSIDASE INHIBITOR; CASTANOSPERMINE 6 BUTYRATE; CASTANOSPERMINE DERIVATIVE;

ANIMAL CELL; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; BRAIN INFECTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG TISSUE LEVEL; GAS CHROMATOGRAPHY; HERPES SIMPLEX VIRUS 1; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; VERO CELL; VIRUS INFECTION;

ACYCLOVIR; ADMINISTRATION, ORAL; ANIMAL; ANTIVIRAL AGENTS; BRAIN; COMPARATIVE STUDY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HERPES SIMPLEX; INDOLIZINES; MICE; MICE, INBRED BALB C; SIMPLEXVIRUS; TIME FACTORS;

EID: 0028952936     PISSN: 09596658     EISSN: None     Source Type: Journal    
DOI: 10.1093/glycob/5.2.249     Document Type: Article

References (18)

1. Anderson, D.C, Schmalstieg, F.C, Finegold, MJ., Hughes, BJ., Rothlein, R., Miller, LJ., Kohl, S., Tosi, M.F., Jacobs, R., Waldrop, T.C, Goldman, A.S., Shearer, W.T. and Springer, T.A. (1985) The severe and moderate phenotypes of heritable Mac-1, LFA-1 deficiency: their quantitative definition and relation to leukocyte dysfunction and clinical features. J. Infect. Dis., 152, 668-689.
2. Bergstrom, T., Sjorgren-Jansson, E., Jeansson, S. and Lycke, E. (1992) Mapping neuroinvasiveness of the herpes simplex virus 1 encephalitis inducing strain 2762 by the use of monoclonal antibodies. Mol. Cell. Probes, 6, 41-96.
3. Boerman, R.H., Peters, A.C.B., Bloem, B.R., Raap, A.K. and van der Ploeg, M. (1992) Spread of herpes simplex virus to the cerebrospinal fluid and the meninges in experimental mouse encephalitis. Ada Neurvpathol., 83, 300-307.
4. Bridges, C.G., Brennan, T.M., Taylor, D.L., McPherson, M. and Tyms, A.S. (1994) The prevention of cell adhesion and the cell-to-cell spread of HIV-1 in vitro by the ct-glucosidase 1 inhibitor, 6-O-butanoyl castanospermine (MDL 28,574). Antiviral Res., 25, 169-175.
5. Bridges, C.G., Taylor, D.L., Kang, M.S., Brennan, T.M. and Tyms, A.S. (1995) Treatment with the a-glucosidase 1 inhibitor 6-O-butanoyl castanospermine reduces the detection of LFA-1 (CD18/CDlla) by monoclonal antibodies. Glycobiology, 5, 243-248.
6. Gateíey, A., Gander, R.M., Johnson, P.C, Kit, S., Otsuka, H. and Kohl, S. (1990) Herpes simplex virus type 2 meningoencephalitis resistant to acyclovir in a patient with AIDS. J. Infect. Dis., 161, 711-715.
7. Izumi, K.M. and Stevens, J.G. (1990) Molecular and biological characterization of a herpes simplex type 1 neuroinvasiveness gene. J. Exp. Med., 172, 487-496.
8. Lobe, D.C, Spector, T. and Ellis, M.N. (1991) Synergistic topical therapy by acyclovir and Al 110U for herpes simplex virus induced zosteriform rash in mice. Antiviral Res., 15, 87-100.
9. Ljungman, P., Ellis, M N., Hackman, R.C, Shepp, D.H. and Meyers, J.D. (1990) Acyclovir resistant herpes simplex virus causing pneumonia after marrow transplantation. J. Infect. Dis., 162, 244-248.
10. Ruprecht, R.M., Mullaney, S., Andersen, J. and Bronson, R. (1989) In vivo analysis of castanospermine, a candidate antiretroviral agent. J. Acq. immun. Def. Synd.,2, 140-157.
11. Ruprecht, R.M., Bernard, L.D., Bronson, R. Gama Sosa, M.A. and Mullaney, S. (1991) Castanospermine vs. its 6-O-butanoyl analog: a comparison of toxicity and antiviral acitivity in vitro and in vivo. J. Acq. Imntun. Def. Sxnd., 4, 48-55.
12. Simmons, A. and Nash, A.A. (1984) Zosteriform spread of herpes simplex virus as a model of recrudescence and its use to investigate the role of immune cells in prevention of recurrent disease. J. Virol. 52, 816-821.
13. Sunkara, P.S., Kang, M.S., Bowlin, T.L. Liu, P.S. Tyms, A.S. and Sjoerdsma, A. (1990) Inhibition of glycoprotein processing and HIV replication by castanospermine analogues. Ann. NY Acad. Sci. 616. 90-96
14. Taylor, D.L., Fellows, L.E., Farrar, G.H., Nash, R.J., Taylor-Robinson, D., Mobberley, M.A., Ryder, T.A., Jeffries, DJ. and Tyms, A.S. (1988) Loss of cytomegalovirus infectivity after treatment with castanospermine or related plant alkaloids correlates with aberrant glycoprotein synthesis. Antiviral Res., 10, 1-26.
15. Taylor, D.L., Sunkara, P., Liu, P.S., Kang, M.S., Bowlin, T.L. and Tyms, A.S. (1991) 6-O-butanoyl castanospermine (MDL 28,574) inhibits glycoprotein processing and the growth of HIVs. AIDS, 5, 693-698.
16. Taylor, D.L., Kang, M., Brennan, TM., Bridges, C.G., Sunkara, P. and Tyms, A.S. (1994) Inhibition of a-glucosidase 1 of the glycoprotein processing enzymes by 6-O-butanoyl castanospermine (MDL 28,574) and its consequences in HIV infected and uninfected T cells. Antimicrob. Agents Chemother., 38, 1780-1787.
17. Tyms, A.S., Scamans, E.M. and Naim, H.M. (1981) The in vitro activity of acyclovir and related compounds against cytomegalovirus infections.J Antimicrob. Chemother., 8, 65-72.
18. Yuhasz, S.A. and Stevens, J.G. (1993) Glycoprotein B is a specific determinant of herpes simplex type 1 neuroinvasiveness. J. Virol, 67, 5948-5954.